Background: Lipoprotein lipase (LPL) is the rate-limiting enzyme in the hydrolysis of core triglycerides in chylomicrons and VLDL. Methods: We investigated the association between the HindIII polymorphism of the LPL gene and fasting glucose, lipid, and lipoprotein concentrations in 683 Caucasians. We first stabilized the study subjects, using an 8-day diet and exercise intervention program before obtaining blood samples. The use of this standardization period reduced the variance of all glucose and lipid concentrations. Results: In our study, the HindIII allele frequencies for females and males were 0.29 and 0.34 for H؊ and 0.71 and 0.66 for H؉, respectively. We found in females, but not in males, a significant association between the HindIII genotype and total cholesterol (P ‫؍‬ 0.007) and LDL-cholesterol (P ‫؍‬ 0.018), with females homozygous for the rare H؊ allele having the lowest, heterozygotes (H؊/؉) having intermediate, and women homozygous for the common H؉ allele having the highest of each of these lipid traits. With regard to triglycerides, HDLcholesterol, and glucose, no significant effect of the HindIII genotype was noted in either gender. Conclusions: These results suggest that in a genderspecific manner, the rare LPL HindIII H؊ allele has a cholesterol-lowering and, therefore, potentially cardio-
The primary function of lipoprotein lipase (LPL) 4 is the hydrolysis of the core triglycerides of circulating chylomicrons and VLDL (1 ) . LPL releases monoglycerides and free fatty acids, which are taken up by skeletal muscle or adipose tissue (2, 3 ) . LPL is also believed to enhance the binding of apolipoprotein E-containing lipoproteins to the LDL receptor-related protein, affecting catabolism of chylomicron remnants (4 ) . In addition, during lipolysis, apolipoproteins and phospholipids are transferred from triglyceride-rich lipoproteins to HDL3 particles to form HDL2 particles. This transfer accounts for the positive correlation between postheparin plasma LPL activity and plasma HDL2 concentrations (5 ) . HDL2 particles play a crucial role in "reverse cholesterol transport" by taking up tissue cholesterol and transporting it to the liver for excretion. HDL2 concentrations and the extent of coronary heart disease (CHD) appear to be inversely related (6 -8 ) . Hence, variability of LPL activity may represent a risk factor for CHD (9 ) . LPL can be synthesized in skeletal muscle; in adipose, heart, lung, and brain tissue; and in macrophages (10 ) . Its physiological location, however, is on the luminal surface of the capillary endothelium (11 ) .
The human LPL gene is located on chromosome 8p22 (12 ) , and its gene structure and cDNA have been described (13) (14) (15) (16) (17) . Several restriction fragment length polymorphisms in the LPL gene have been documented and associated with various lipid traits (18 -21 ) . This study focused on the LPL HindIII polymorphism in which a replacement of a thymine (T) with a guanine (G) base occurs at position ϩ495 in intron 8 and abolishes a HindIII restriction enzyme recognition site (22 ) . It has been hypothesized that the more common Hϩ allele (presence of cutting site) is associated with a lower LPL activity compared with the rare HϪ allele (absence of the restriction site). As such, it has been proposed that carriers with the Hϩ/ϩ genotype have higher triglyceride concentrations and lower HDL concentrations vs carriers of the HϪ/Ϫ genotype.
Although in some studies the common Hϩ allele of the LPL HindIII polymorphism has been shown to be significantly associated with hypertriglyceridemia (23) (24) (25) (26) (27) (28) , hypercholesterolemia (9 ), lower HDL (9, 29, 30 ) , increased apolipoprotein C-III (30 ) and apolipoprotein B (27 ) , and premature CHD (24, 27, 29, 30 ) , other reports failed to note such effects (23, (31) (32) (33) . The inconsistency of those reports may be attributable to small sample sizes or heterogeneity with regard to the ethnic backgrounds, ages, and sexes of study subjects. More importantly, differences in diet and lifestyle may have been responsible for this disparity. Previous studies failed to account for dietary influences that have been reported to have an effect on LPL activity (34, 35 ) .
Therefore, the aims of this study were (a) to reduce the variability of various lipoprotein phenotypes by stabilizing study subjects with the help of a dietary and lifestyle intervention program before analysis; (b) to investigate associations between the LPL HindIII genotypes and several lipid traits in a large study population; and (c) to identify the gene-gender difference of this polymorphism regarding lipid and lipoprotein concentrations.
Subjects and Methods subjects
A total of 683 middle-aged and elderly subjects participated in this study. All study subjects (342 females and 341 males) took part in a lifestyle intervention program at a residential center in California, which included a lowfat/low-cholesterol, but high-complex carbohydrate/ high-fiber diet. Furthermore, people participated in a daily exercise program that included 30 -40 min of walking and 60 min of supervised fitness classes. This program previously has been described in detail (36 ) . Fasting blood samples were drawn after a period of 8 days. Some data suggest that this diet period in combination with physical activity produces sufficient normalization of plasma lipid concentrations (37, 38 ) . Information on the study subjects is provided in Table 1 . The menopausal status of women was not assessed.
blood sampling
All subjects were sampled after an 8-day intervention period and an overnight fast of at least 12 h. Blood samples were placed in SST clot-activating gel tubes (Becton-Dickinson Vacutainer System) or in two 10-mL EDTA tubes (1 g/L EDTA) for the isolation of DNA. Serum was used for the determination of serum lipids and glucose. Non-HDL lipoproteins were precipitated using the sodium phosphotungstic acid reagent. The total cholesterol, HDL-cholesterol, triglyceride, and glucose concentrations were measured using standard automated enzymatic procedures on an Olympus automated analyzer (Smith-Kline Beecham Laboratories). LDL-cholesterol was calculated by subtracting the sum of the HDLcholesterol and triglycerides divided by 5 from total cholesterol, as described by Friedewald et al. (39 ) , provided triglyceride concentrations were Ͻ4.52 mmol/L (400 mg/dL).
genotyping
Genomic DNA was isolated from whole blood, using the QIAamp Blood Kit (Qiagen). The HindIII genotype in intron 8 of the LPL gene was determined by PCR followed by digestion with the restriction endonuclease HindIII and agarose gel electrophoresis as described previously (27 ) . The resulting restriction fragment length polymorphism fragments were 356 bp (uncut) for the HϪ allele or 217 and 139 bp (cut) for the Hϩ allele. In 180 randomly selected individuals, the S447X mutation of LPL was also assessed as described (40 ) .
statistical analysis
Statistical analysis was performed with the software package SPSS/PCϩ. The statistical significance was set at ␣ ϭ 0.05. Allele frequencies for the HindIII polymorphic site were estimated by gene counting. Agreement of the genotype frequencies with the Hardy-Weinberg equilibrium expectations was tested using a 2 goodness-of-fit test. All variables were tested for gaussian distribution. Data for body mass index (BMI), plasma glucose, HDL, and triglycerides were log 10 transformed before analysis of covariance to reduce the skewness of the data. The antilogs and unadjusted mean values Ϯ SD of the lipid traits are presented in Tables 2 and 3 . Analyses were performed separately in females and males. Comparisons of the glucose, lipid, and lipoprotein traits between females and males were performed with the Student t-test. Covariance adjustments were made for age, BMI, smoking status, alcohol use, and medications (cholesterollowering drugs, diabetes medication, hormonal replacements, and thyroid supplementation). Analysis of covariance was performed to test the null hypothesis that phenotypic variations in these traits were not associated with genetic variation at the candidate gene locus. The continuous variables (age and BMI) were entered in the general linear model as covariates. The dichotomous variables (smoking status, alcohol use, and medications) were included as factors. In cases involving significant effects of genetic variability on lipid traits, one-way ANOVA (Tukey test) was performed to compare interindividual differences between genotypes.
Results
The data on the biochemical variables for females and males are listed in Table 2 . Males had higher concentrations of fasting plasma glucose and triglycerides and lower total cholesterol and HDL-cholesterol compared with females. For LDL-cholesterol, no gender difference was observed. For both women and men, the genotype distributions were in accordance with the Hardy-Weinberg expectation. The rarer HϪ allele occurred at a frequency of 0.29 in women and 0.34 in men. The common Hϩ allele occurred at a frequency of 0.71 in women and 0.66 in men (Table 3 ). These data indicated no statistical significant difference between females and males with regard to HindIII genotype distribution. Investigation of the HindIII polymorphism and the LPL S447X variant revealed in a random subset of 180 subjects (data not shown) a significant linkage disequilibrium between these two polymorphisms, as described previously (40 ) .
The data on the biochemical variables by gender and LPL HindIII genotype are listed in Table 4 . With regard to total cholesterol, females showed a significant association (P ϭ 0.007) between the HindIII genotypes and total cholesterol: Women homozygous for the HϪ allele had the lowest total-cholesterol concentrations, those being heterozygous had intermediate concentrations, and women carrying both Hϩ alleles had the highest concentrations. The same gene-dosage effect was also observed in women with regard to LDL-cholesterol. Whereas women having the HϪ/Ϫ genotype had the lowest LDL concentrations, at 2.55 mmol/L, those having the Hϩ/ϩ genotype had the highest concentrations, at 2.98 mmol/L (P ϭ 0.018). The same trend, although not statistically significant, was noted if women on hormone replacement therapy were tested separately (data not shown). In the male population, no significant difference between the HindIII genotype and total cholesterol or LDL-cholesterol was found. HDL-cholesterol and triglyceride concentrations showed no difference in either gender.
Discussion
LPL is known to be the rate-limiting enzyme in triglyceride catabolism. Knowing that environmental factors such as diet and lifestyle can significantly influence the lipid and lipoprotein concentrations, we took a new approach and reduced the variability of those factors on lipid traits by placing all study subjects on a low-fat, low-cholesterol diet, exercise, and lifestyle modification program before analysis. By recruiting a large number of people, we could study a possible gene-gender interaction.
The genotype distribution of the HindIII polymorphism in this study was not significantly different from the Hardy-Weinberg equilibrium, and the overall allele frequencies were similar to previously published studies in Caucasians (9, 23, 24, 29, 30, 32, 33 ) .
In females, the Hϩ allele was associated with higher concentrations of total cholesterol and LDL-cholesterol. There was a clear gene-dosage effect in females, with Hϩ homozygotes having the highest cholesterol concentrations, heterozygotes having intermediate concentrations, and HϪ homozygotes having the lowest concentrations. In males, however, no effect was observed for total and LDL-cholesterol. The majority of previous studies did not find significant associations between the LPL HindIII genotype and total or LDL-cholesterol. Mattu et al. (27 ) , however, also reported an association between the HindIII Hϩ allele and total and LDL-cholesterol as well as the gene-dosage effect, with Hϩ subjects having the highest and HϪ subjects having the lowest lipid concentrations. Clinical Chemistry 45, No. 7, 1999 Our results may now provide an explanation for previously reported associations of the Hϩ allele and CHD (24, 27, 41, 42 ) . Thorn et al. (24 ) reported in Caucasians with severe coronary artery disease a significantly higher frequency of the Hϩ allele compared with healthy controls. Furthermore, Chen et al. (41 ) not only indicated that individuals with the Hϩ/ϩ genotype had a significantly higher mean carotid wall thickness, but that the Hϩ/ϩ genotype was also associated with hypertriglyceridemia and hypercholesterolemia. Patients with type 2 diabetes mellitus and the Hϩ/ϩ genotype were reported to have the highest prevalence of CHD (90%) compared with the HϪ/ϩ (55.4%) and HϪ/Ϫ (54.6%) genotypes, respectively (43 ) .
It is believed that the HindIII polymorphism is in linkage disequilibrium with one or more regions within or in close proximity to the LPL gene, affecting LPL activity and/or the clearance rate of triglyceride-rich lipoproteins and their remnants. In fact, a recent report by Humphries et al. (40 ) provides strong evidence for significant linkage disequilibrium between the HindIII site and the LPL S447X mutation. Recently, it has been shown that the S447X mutation is associated with increased LPL activity (44 ) . Therefore, individuals with the HindIII site and the LPL wild type would be expected to have lower LPL activity. Our results can also be compared with patients who are heterozygous for familial LPL deficiency and are characterized by LPL activity reduced by 50%. Brunzell (45 ) and Miesenboeck et al. (46 ) detected in some of these patients abnormalities across the lipoprotein density spectrum, including an increase in VLDL or intermediatedensity lipoproteins and small, dense LDL particles. Furthermore, this alteration in lipoprotein composition might cause a reduced affinity of those particles to the LDL receptor, which could explain the higher LDL concentrations. In addition, nonenzymatic effects of LPL, such as its bridging function, may be more efficient in individuals with the S447 stop mutation (40 ) .
We could not demonstrate a significant association between the HindIII genotype and HDL-cholesterol or triglycerides in either females or males. Assuming that the polymorphism is associated with the LPL activity, one would expect to find lower HDL-cholesterol and higher triglyceride concentrations in carriers with the Hϩ allele. Humphries et al. (40 ) , who studied the effects of the HϪ X447 haplotype on triglyceride concentrations, demonstrated that the impact, although significant, was small. Hence, our findings do not rule out an association between the HindIII polymorphism and LPL activity. It is also conceivable that LPL activity in individuals with the Hϩ allele was still high enough for effective triglyceride hydrolysis; however, LPL activity was already too low to facilitate efficient uptake of remnants, leading to increased LDL concentrations (47, 48 ) . Affected individuals may exhibit increased triglyceride concentrations only after an alimentary triglyceride load or lack of physical activity.
In terms of the gene-gender effect, a difference with regard to the LPL HindIII polymorphism and various lipid traits was noted. At present, we can only speculate about the underlying mechanism. The metabolic reason for this gene-gender difference might be related to hormones, but further investigation is needed before a hypothesis can be put forward. 
